Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

OBJECTIVE: To evaluate the cost-effectiveness of obinutuzumab in combination with chlorambucil (GClb) versus rituximab plus chlorambucil (RClb) in the treatment of adults with previously untreated chronic lymphocytic leukemia (CLL) and with comorbidities that make them unsuitable for full-dose fluda...

Descripción completa

Detalles Bibliográficos
Autores principales: Casado, Luis Felipe, Burgos, Amparo, González-Haba, Eva, Loscertales, Javier, Krivasi, Tania, Orofino, Javier, Rubio-Terres, Carlos, Rubio-Rodríguez, Darío
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036824/
https://www.ncbi.nlm.nih.gov/pubmed/27703384
http://dx.doi.org/10.2147/CEOR.S114524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036824/
https://www.ncbi.nlm.nih.gov/pubmed/27703384
http://dx.doi.org/10.2147/CEOR.S114524

Ejemplares similares